Bridgeway Capital Management, LLC Blueprint Medicines Corp Transaction History

Bridgeway Capital Management, LLC

  • $4.44 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$82.78 - $101.0 $380,788 - $464,600
-4,600 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$90.71 - $108.28 $108,851 - $129,936
1,200 Added 35.29%
4,600 $447,000
Q4 2020

Feb 16, 2021
BUY
$92.08 - $124.48 $313,072 - $423,232
3,400 New
3,400 $381,000

Others Institutions Holding BPMC

# of Institutions
349
Shares Held
60.2M
Call Options Held
1.05M
Put Options Held
616K
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.71B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email